openPR Logo
Press release

Global Tumor Ablation Market Outlook To 2026

03-11-2020 08:24 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Ameri Research Inc.

/ PR Agency: Director
Tumor Ablation Market

Tumor Ablation Market

Global Tumor Ablation Market Outlook To 2026: In-Depth Market Overview, Key Treatment Type (Surgical, Percutaneous), Technology (Cryoablation, IRE, MWA, RFA), Application Categories (Liver, Lung, Breast, Prostate), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast And Conclusion

The Tumor Ablation Market was valued at $1.08Billion in 2018 and is forecast to grow at a modest12.2% CAGR between2018 and 2025, culminating in 2026 global sales of $4.2Billion.

Tumor Ablation is the application of intense cold, heat or ethanol to destroy cancer cells and tumors of the bone, lung, kidney, and liver. Tumor ablation is a method that confirmed higher effectiveness of tumor cell treatment with minimum side effects or toxicity. This method of treatment includes the destruction of tumors using chemical agents, heat, and low temperature that are initiated into the tumor regions using a guided needle through a small hole. Tumor ablation therapy demonstrates to be an excellent selection over other conventional procedure of treatment owing to its least invasiveness. Those patients are unable to take surgery for medical reasons. It was proved to be very effective and safe in the treatment of patients having few tumors more than three or partial to a smaller, larger and greater number of tumors. Rising public awareness campaign in order to identify cancer at the beginning stage and the fund provided by the government is anticipated to boost the tumor ablation market. According to WHO there are 18.2 Million of cancer patient were detect in 2018 and this will propel the market demand over the forecast period. Helpful government enterprises, for example, National Cancer Control Programmes (NCCP), which objects are only reduced cancer prevalence and enhancing the standard quality care with affordable cost.

Click the link below to view the report description:

www.ameriresearch.com/product/tumor-ablation-market/

Key findings from the study: -
o The Tumor Ablation Market was valued at $1.08 Billion in 2018 and is forecast to grow at a modest 12.2% CAGR between 2018 and 2025, culminating in 2026 global sales of $4.2 Billion.
o Collagen is the most plentiful protein in the mammal's body, forms in the tendons, muscles, skin, and bones. It is the element that having 25%-30% total weight of the protein holds the body together. Collagen support to provide strength and structure to the cells in the tissue. This Protein made up of arginine, hydroxyproline, proline, glycine, and amino acids, all of which benefit our body's connective tissues.
o We have segmented the Global Tumor Ablation Market based on Treatment Type as Surgical, Percutaneous.
o We have segmented the Global Tumor Ablation Market based on Technology Type as Cryoablation, IRE, MWA, RFA.

Ameri Research has segmented the Global Tumor Ablation Market by material categories, product type, end-use and region:

Market Segmentation
Global Tumor Ablation Market by Key Treatment Type(Revenue, Million, 2018 - 2026)
o Surgical
o Percutaneous

Global Tumor Ablation Market by Application Type (Revenue, Million, 2018 - 2026)
o Cryoablation
o IRE (Irreversible Electroporation)
o MWA (Microwave Ablation)
o RFA(Radio frequency Ablation)

Global Tumor Ablation Market by Source Type (Revenue, Million, 2018 - 2026)
o Liver
o Lung
o Breast
o Prostate

Global Tumor Ablation Market Regional Outlook (Revenue, USD Million, 2018-2026)
o North America
o U.S.
o Canada
o Europe
o UK
o Germany
o France
o Italy
o Spain
o Asia Pacific
o Japan
o China
o India
o Australia
o Latin America
o Brazil
o Mexico
o Columbia
o Middle East and Africa
o South Africa
o Saudi Arabia

BrowseFullReport@ www.ameriresearch.com/product/tumor-ablation-market/

Contact Us:
Ameri Research Inc.
Tel: 1-813-666-0858
Email: nibedita@ameriresearch.com
Web: www.ameriresearch.com

About Us:
Ameri Research Inc. (www.ameriresearch.com) is a U.S. based market research and consulting company, registered in the State of Florida and headquartered in Tampa Bay Area. At Ameri Research we are passionately curious about people, markets, brands and society. Our ability to gauge market movements, deep expertise in data science, strong domain expertise and years of collective global experiences helps us to bring unmatched quality in deliverables to our clients. With carefully planned systems and processes in place, we cater to the requirements of our clients in a timely and cost-efficient manner, bringing increased predictability to their business. Each year we are publishing more than 100 syndicated reports in healthcare, chemicals, materials, food & beverages, defense & aerospace, media & entertainment, sports & fitness, and energy. We offer our clients a unique depth of knowledge and expertise around-

Market Mapping
Opportunity Assessment
Positioning
Pricing Analysis
Market Entry Strategy
Competitive Intelligence
Program Evaluation
Performance Reporting
Data Analytics
Developing a culture of collaboration and curiosity, we attract the highest caliber of likeminded people having ability to influence and shape the future.

Follow us on LinkedIn for our latest upcoming reports www.linkedin.com/company/ameri-research-inc./
Follow us on Facebook for our latest upcoming reports www.facebook.com/AmeriResearchInc/
Follow us on Twitter for our latest upcoming reports www.twitter.com/AmeriResearch

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Tumor Ablation Market Outlook To 2026 here

News-ID: 1961411 • Views: 293

More Releases from Ameri Research Inc.

Global Stem Cell Market Outlook To 2026
Global Stem Cell Market Outlook To 2026: Key Product Categories (Adult, HESC, Induced Pluripotent), Application (Regenerative Medicine, Drug Discovery & Development), Therapy (Autologous, Allogenic), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast, And Conclusion The Stem Cell Market was valued at $9.10Billion in 2018 and is forecast to grow at a modest9.8 % CAGR between2018 and 2025, culminating in 2026 global sales of $17.20Billion. Increase in the
Wireless Broadband Market Outlook To 2024
Wireless Broadband Market Outlook To 2024: Key Technology Categories (LMDS, MMDS, PCS), Application (Residential, Commercial), Regional Segmentation, Competitive Dynamics, M&A Insights, Pricing Analysis (IPP, OPP, RAP) And Segment Forecast The global wireless broadband market was valued at $10.6bn in 2016 and is forecast to grow at a strongCAGR of 10.6% between 2017 and 2024, culminating to global revenue of $23.5bn by 2024. Industry at a Glance With growing social media communication,
Offshore Drilling Market Outlook To 2024
Offshore Drilling Market Outlook To 2024: In-Depth Market View, Key Service Categories (Directional Drilling, Measurement While Drilling, Contract Drilling, Logging While Drilling), Application (Shallow, Deepwater, Ultra-Deep Water), Regional Segmentation, Top Players & Company Share, Competitive Dynamics, Growth Drivers & Restraints, Pricing Analysis, Segment Forecast And Key Conclusion The global offshore drilling market was valued at $89.5 billion in 2016 and is forecast to grow at a steady CAGR of 5.2% between
Global Hyaluronic Acid Market Outlook To 2026
Global Hyaluronic Acid Market Outlook To 2026: In-Depth Market Overview, Key Application Types (Dermal Fillers, Osteoarthritis [Single Injection, Three Injection, Five Injection], Ophthalmic, Vesicoureteral Reflux), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast, And Conclusion The Hyaluronic Acid Market was valued at $xx.9Billion in 2018 and is forecast to grow at a modestxx.6 % CAGR between2018 and 2025, culminating in 2026 global sales of $xx.7Billion. Hyaluronic Acids

All 5 Releases


More Releases for Tumor

Global Tumor Ablation Devices Market - Insights
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012. Click To Continue Reading: https://www.coherentmarketinsights.com/market-insight/tumor-ablation-devices-market-1270 Tumor Ablation devices market
Global Tumor Ablation Devices Market - Insights
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators,
Tumor Ablation Market: Industry Evolution/Development
A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market
Tumor Necrosis Factor Receptor
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017” Tumor Necrosis Factor Overview Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed
Personalised tumor vaccines keep cancer in check
Throughout the last decade, novel cancer therapeutics has seen tremendous developments, through targeting tumor cell-intrinsic pathways, as well as targeting tumor cell-extrinsic factors such as growth factors. Notable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T-cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies. This creates the need for
Global Neuroendocrine Tumor Treatment Market
The Global Neuroendocrine Tumor Treatment Market was valued at US$ 1,197.3 million in 2016 and is projected to expand at a CAGR of 10.5% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Better diagnostic techniques and products in pipeline are expected to be major factors driving growth of the global neuroendocrine tumor treatment market over the foreseeable future. Neuroendocrine Tumor (NET) are diagnosed